Design, synthesis and biological evaluation of (E)-2-(2-arylhydrazinyl)quinoxalines, a promising and potent new class of anticancer agents

Felipe A.R. Rodrigues, Igor da S. Bomfim, Bruno C. Cavalcanti, Claudia do Ó. Pessoa, James L. Wardell, Solange M.S.V. Wardell, Alessandra C. Pinheiro, Carlos Roland Kaiser, Thais C.M. Nogueira, John N. Low, Ligia R. Gomes, Marcus V.N. de Souza
  • Bioorganic & Medicinal Chemistry Letters, February 2014, Elsevier
  • DOI: 10.1016/j.bmcl.2013.12.074

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.bmcl.2013.12.074

The following have contributed to this page: Dr John N Low